Compare Abeona Therapeutics Inc (ABEO) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Amylx Pharmaceuticals Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B). The key difference: Amylx Pharmaceuticals Inc is far larger — about 6.3× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AMLX | |
|---|---|---|
Market Cap | $421.19M | $2.64B |
Sector | Health | Health |
52-Week High | $7.45 | $24.19 |
52-Week Low | $4.17 | $7.82 |
Enterprise Value | $276.10M | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
